Back To: Home

Our 2017 Media Kit is now available
Your gateway to the latest oncology news, trends and resources
Inside this issue:
June 2017
Metabolomics shifts from map-making to therapeutic strategizing...
by Randall C Willis
June 2017
Collaborative work from Heptares and AstraZeneca reveals X-ray crystal structures of a GPCR of interest...
by Kelsey Kaustinen
June 2017
Trial combines Regeneron’s PD-1 inhibitor and Inovio’s T cell and immune activators in glioblastoma multiforme...
by Mel J. Yeates
June 2017
Immunovaccine, Idera and Sunesis all share preclinical research results at AACR 2017...
by Jeffrey Bouley
Top Story
Post-show wrap-up: Digging deep into IO at AACR
In the June 2017 issue of DDNews, we decided to go the reverse direction of our show previews and do a post-show feature for AACR (which, as it happens, we had also previously done a preview of earlier in the year) to give you an extra boost in our cancer-related coverage of pharma and biotech

Editor's Focus:
June 2017
Scientific papers and presentations are good, but have we reached the point there are so many journals and so many conferences that we are losing serious ground with regard to how many of them are reputable, valuable and/or to be trusted?.. [ more ]
by Peter T. Kissinger

June 2017
FDA’s approval of Merck & Co.’s pembrolizumab marks a watershed moment, heralding the possible era of 'tumor-agnostic' drug approvals.. [ more ]
by Jeffrey Bouley

May 2017
The associate director in the Product Management group at Taconic Biosciences takes a look at where CRISPR has been, where it is now, where it is going and what that could all mean for getting the most out of this popular gene-editing technology.. [ more ]
by Dr. Adriano Flora

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by Offenberger & White.